近4年累计亏损17亿元,君圣泰医药进入重要闯关期 董事长刘利平:计划年底递交新药上市申请

每日经济新闻
May 09, 2025

5月8日下午,君圣泰医药在深圳证券交易所举行了投资者交流会,会议主题围绕“一药多效”,公司创始人、行政总裁(CEO)及董事长刘利平,副总经理及执行董事于萌,董秘及投资者关系总监高丽萍等多名高管出席了会议。交流会开始的时间,比预期晚了几分钟。一开场,高丽萍简短介绍会议议程后,就直白介绍起君圣泰医药产品主要是聚焦代谢性慢病开发赛道,而公司开发核心产品熊去氧胆小檗碱(HTD1801)的理念,则是基于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10